• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconVaccines

Vaccines

Page 26 of 31
Woman in a white lab coat and pink rubber gloves holding a vial of purple liquid.
HealthScientists to Wall Street: You don’t really understand how COVID vaccine tests work
By Jeremy KahnAugust 24, 2020
Syringe shown against the AstraZeneca logo
HealthAstraZeneca denies it is in discussions to fast-track U.S. approval of its COVID-19 vaccine
By Jeremy KahnAugust 24, 2020
Oxford-Vaccine-Trials-Kaiser-Health-News
HealthOxford’s COVID vaccine deal with AstraZeneca raises concerns about access and pricing
By Jay Hancock, Kaiser Health NewsAugust 24, 2020
Australia signs a deal for AstraZeneca’s COVID vaccine—and considers making it mandatory
HealthAustralia signs a deal for AstraZeneca’s COVID vaccine—and considers making it mandatory
By Naomi Xu ElegantAugust 19, 2020
COVID-19-Vaccine Trial
CommentaryWhat’s the backup plan if a COVID-19 vaccine comes up short?
By Hansa Bhargava and John WhyteAugust 14, 2020
How reborn pharma giant AstraZeneca is taking the lead against COVID-19
MagazineHow reborn pharma giant AstraZeneca is taking the lead against COVID-19
By Jeremy KahnAugust 10, 2020
Who should get get the COVID-19 vaccine?
CommentaryWhen rationing a coronavirus vaccine, pharma must keep these 3 ethical considerations in mind
By Mike ReaJuly 23, 2020
Britain's Prince William visiting an Oxford lab where they are working on a Covid-19 vaccine.
HealthA promising COVID-19 vaccine from Oxford and AstraZeneca just cleared a key safety hurdle
By Jeremy KahnJuly 20, 2020
vaccine injections
CommentaryHow to speed up medical breakthroughs in the post-COVID world
By Paul HudsonJuly 15, 2020
Photo of Covid-19 on stock exchange graph.
FinanceWill we have a COVID-19 vaccine this year? Here’s what the prediction markets say
By Jeremy KahnJuly 15, 2020
Moderna’s coronavirus vaccine produced antibodies in all patients tested
HealthModerna’s coronavirus vaccine produced antibodies in all patients tested
By BloombergJuly 14, 2020
Moderns stock price rise on COVID-19 vaccine.
HealthAnalyst predicts COVID-19 vaccine could generate $5 billion in sales
By BloombergJuly 13, 2020
Brainstorm Health 2020-Alex Gorsky
NewslettersJohnson & Johnson’s CEO on building trust for a coronavirus vaccine
By Sy MukherjeeJuly 9, 2020
Brainstorm Health 2020-Alex Gorsky
ConferencesJohnson & Johnson CEO says a COVID-19 vaccine is only ‘part of the puzzle’
By Beth KowittJuly 8, 2020
In the COVID-19 vaccine race, nobody wins unless everyone wins
CommentaryIn the COVID-19 vaccine race, nobody wins unless everyone wins
By Seth BerkleyJuly 8, 2020
1...
  • 24
  • 25
  • 26
  • 27
  • 28
...31
Most Popular
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
Energy
2 years ago, Saudi Arabia quietly canceled the ‘petrodollar’ deal with America that wired the world economy for 50 years. Then war broke out in Iranplaceholder alt text
By Fortune EditorsApril 7, 2026
Success
Gen Z doesn't want your full-time job. They want several part-time roles, and it's reshaping the entire workforceplaceholder alt text
By Fortune EditorsApril 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.